On October 20, 2020, Blue Matter led a webinar in coordination with Fierce Markets entitled, Pathways to Value: Biopharma’s Options for Global Expansion. Speakers were:
- Theo Manolikas, Principal, Blue Matter Consulting (moderator)
- Thomas Lackner, Senior Vice President, Head of Europe, Apellis Pharmaceuticals
- Michelle Lock, Former Senior Vice President, Head of Europe, Sage Therapeutics
During the webinar, the speakers:
- Identified the key pathways companies use to enter ex-US markets (e.g., licensing, partnering, “going it alone”)
- Discussed the factors that might favor one pathway over another
- Outlined a framework that companies can use to decide the optimum pathway for their situations
- Provided insights from their experience in ex-US markets
The presentation that was used to facilitate the session is available for download via this page.
